Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SHAZEL GHARBI

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1134449713
CMS profile
51872
Location
CHICAGO, IL

General Payments · PY2018–2024

$15,561.23

  • Reported across 139 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,391.13

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,391.13 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
MERZ NORTH AMERICA, INC. $1,167.90 11
Galderma Laboratories, L.P. $223.23 5

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,497.20 30
PY2019 $2,562.71 36
PY2020 $315.72 5
PY2021 $6,545.32 23
PY2022 $2,068.77 16
PY2023 $1,180.38 13
PY2024 $1,391.13 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Galderma Laboratories, L.P. $41.44 02/27/2024 Food and Beverage Undisputed 01/23/2026 1145299352 CMS
Galderma Laboratories, L.P. $41.50 07/19/2024 Food and Beverage Undisputed 01/23/2026 1145299354 CMS
Galderma Laboratories, L.P. $49.45 08/22/2024 Food and Beverage Undisputed 01/23/2026 1145299356 CMS
Galderma Laboratories, L.P. $13.67 12/16/2024 Food and Beverage Undisputed 01/23/2026 1145299358 CMS
Galderma Laboratories, L.P. $77.17 12/19/2024 Food and Beverage Undisputed 01/23/2026 1145299360 CMS
MERZ NORTH AMERICA, INC. $160.12 01/18/2024 Food and Beverage Undisputed 01/23/2026 1146375066 CMS
MERZ NORTH AMERICA, INC. $180.23 02/01/2024 Food and Beverage Undisputed 01/23/2026 1146375068 CMS
MERZ NORTH AMERICA, INC. $105.88 02/23/2024 Food and Beverage Undisputed 01/23/2026 1146375072 CMS
MERZ NORTH AMERICA, INC. $120.14 02/29/2024 Food and Beverage Undisputed 01/23/2026 1146375070 CMS
MERZ NORTH AMERICA, INC. $79.98 03/28/2024 Food and Beverage Undisputed 01/23/2026 1146375078 CMS
MERZ NORTH AMERICA, INC. $23.19 05/01/2024 Food and Beverage Undisputed 01/23/2026 1146375076 CMS
MERZ NORTH AMERICA, INC. $168.73 05/02/2024 Food and Beverage Undisputed 01/23/2026 1146375074 CMS
MERZ NORTH AMERICA, INC. $128.05 07/10/2024 Food and Beverage Undisputed 01/23/2026 1146375080 CMS
MERZ NORTH AMERICA, INC. $109.51 10/06/2024 Food and Beverage Undisputed 01/23/2026 1146375082 CMS
MERZ NORTH AMERICA, INC. $35.74 10/09/2024 Food and Beverage Undisputed 01/23/2026 1146375084 CMS
MERZ NORTH AMERICA, INC. $56.33 11/05/2024 Food and Beverage Undisputed 01/23/2026 1146375086 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.